CANTHARIDIN 0.7%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-05-17
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:50
Label at a glance#
ProductCANTHARIDIN 0.7%
Active ingredientCANTHARIDIN
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC. Adverse reactions
Active, inactive
NDC 72934- 9035-9 CANTHARIDIN 0.7%. Liquid 15 gm
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9cb53635-25f5-4f32-92e9-047a63fb4e56 | Product name | 1 | 20231023 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-9035-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4530-a910-e053-dadaa90a0b85 | CANTHARIDIN 0.7% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-9035-9 | CANTHARIDIN 0.7% | 15 g in 1 VIAL | LIQUID | 15 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-9035 | CANTHARIDIN 0.7% LIQUID [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190518_891ae88b-bacc-137f-e053-2a95a90a8f7d.zip |
Products#
Every source-derived product name is available through these pages.
- CANTHARIDIN 0.7%
- CANTHARIDIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-9035 | 72934-9035-9 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CANTHARIDIN | IGL471WQ8P | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 891ae88b-bacd-137f-e053-2a95a90a8f7d | 891ae88b-bacc-137f-e053-2a95a90a8f7d | 2019-05-17 | Adverse reactions | 891ae88b-bacd-137f-e053-2a95a90a8f7d 891ae88b-bacc-137f-e053-2a95a90a8f7d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


